Tricuspid Regurgitation

Increased Right Atrial Pressure and Systemic Venous Congestion

• During RV systole, a portion of RV stroke volume is redirected backward through an incompetent tricuspid valve into the right atrium rather than proceeding to the pulmonary circulation
• This retrograde flow increases right atrial (RA) pressure acutely, transmitting pressure backward through the inferior vena cava and superior vena cava, producing systemic venous hypertension
• Elevated mean RA pressures (>8 mmHg) result in distension of the hepatic veins and activation of the hepatic baroreceptor reflex, leading to sympathetic nervous system activation and increased total body sodium retention via renin-angiotensin-aldosterone system (RAAS) activation
• This creates a pathological cycle wherein increased intravascular volume worsens RV dilatation, perpetuating valve incompetence through geometric distortion of the tricuspid annulus (secondary/functional mechanism)
• Chronic elevation of RA pressure (>10-15 mmHg) produces hepatomegaly, ascites, peripheral edema, and eventually hepatic fibrosis and cirrhosis ("cardiac cirrhosis")

Right Ventricular Remodeling and Geometric Annular Dilatation

• The majority of clinically significant TR is secondary (functional) rather than primary, arising from RV dilatation and tricuspid annular enlargement due to diverse causes including left heart failure, pulmonary hypertension, RV infarction, or atrial fibrillation
• In secondary TR, the primary pathology affects the RV geometry rather than the valve leaflets themselves; as the RV chamber enlarges, the tricuspid annulus—an elliptical fibrous structure normally ~25-30 mm in diameter—expands eccentrically, preventing leaflet coaptation
• The septal and anterior leaflets of the tricuspid valve are tethered to the papillary muscles and RV free wall; when the annulus enlarges, the geometric distance between leaflet free margins increases, creating a gap that is particularly pronounced during systole when annular contraction normally produces coaptation
• This annular dilatation is mechanically characterized as papillary muscle displacement: as the RV cavity enlarges, the anteroseptal and posteroinferior papillary muscles are displaced laterally and apically, increasing the distance between muscle insertion points and increasing leaflet tethering
• Progressive RV dysfunction accompanying the underlying etiology (e.g., impaired RV contractility in advanced heart failure) further compromises the forces necessary to bring leaflet edges into apposition

Altered Hemodynamics and Ventricular Interactions

• The increased RV afterload (resistance to ejection) from pulmonary hypertension or RV outflow tract obstruction paradoxically worsens TR by further dilating the RV and annulus; this represents a negative feedback loop
• Atrial fibrillation (present in 50-60% of severe TR cases) loses the contribution of atrial systole to ventricular filling, reduces RV contractility through loss of mechanical synchrony, and increases ventricular dilatation, thereby promoting progressive functional TR
• Leftward interventricular septal bowing occurs in severe RV pressure or volume overload, mechanically restricting left ventricular cavity and paradoxically impairing left ventricular function through a ventricular interdependence mechanism
• The regurgitant jet creates a systolic pressure wave in the inferior vena cava and hepatic veins that can be transmitted retrogradely into the portal venous system, contributing to hepatic congestion and intestinal edema

Cellular and Molecular Mechanisms of RV Dysfunction

• Chronic volume overload from uncorrected TR stimulates RV cardiomyocyte hypertrophy through mechanical stretch-activated pathways, particularly involving TGF-β (transforming growth factor-beta) and Wnt/β-catenin signaling
• Progressive myocardial fibrosis occurs through activation of cardiac fibroblasts by inflammatory cytokines (TNF-α, IL-6) released from volume-overloaded myocardium and from systemic venous congestion-induced intestinal epithelial translocation of bacterial endotoxins (lipopolysaccharide)
• Mitochondrial dysfunction and impaired oxidative metabolism develop in chronically overloaded RV myocardium, reducing ATP production and predisposing to arrhythmias
• Neurohormonal activation (sympathetic nervous system upregulation, increased circulating norepinephrine, RAAS activation) initially serves as a compensatory mechanism but becomes maladaptive chronically, promoting fibrosis, arrhythmias, and apoptosis
• Oxidative stress increases through uncoupling of nitric oxide synthase (eNOS) and increased production of reactive oxygen species (ROS), particularly in the setting of pulmonary hypertension

Mechanisms Linking Primary vs. Secondary TR

• Primary TR results from intrinsic valve leaflet abnormalities (endocarditis-related scarring, rheumatic disease, carcinoid syndrome collagen remodeling, myxomatous degeneration, congenital clefts)—here the geometric problem is leaflet insufficiency
• Secondary TR reflects a normal valve in an abnormal geometric situation—the fundamental abnormality is RV enlargement and annular dilatation, with the valve leaflets remaining structurally intact but functionally incompetent
• A critical concept: secondary TR begets more TR because the volume overload and pressure elevation it produces lead to further RV dilatation, progressive annular enlargement, and worsening of incompetence—this vicious cycle necessitates targeting the underlying cause

Secondary (Functional) Tricuspid Regurgitation (85-90% of significant TR cases)

• Left-Sided Heart Disease with Pulmonary Hypertension: The most common etiology overall. Left ventricular dysfunction from any cause (ischemic heart disease, dilated cardiomyopathy, hypertensive heart disease) leads to elevated pulmonary venous pressure, reactive pulmonary hypertension, and subsequent RV dilatation with secondary TR. This mechanism explains why TR is present in 70-90% of patients with moderate-to-severe left heart failure.

• Pulmonary Hypertension from All Causes: Chronic elevation of RV afterload causes RV remodeling and dilatation in pulmonary arterial hypertension (PAH, both idiopathic and associated forms), chronic thromboembolic pulmonary hypertension (CTEPH), group II (left heart disease-related) pulmonary hypertension, group III (lung disease-related) pulmonary hypertension, and group V (miscellaneous) pulmonary hypertension. The degree of TR often correlates with the magnitude of pulmonary pressure elevation.

• Right Ventricular Infarction: Acute RV myocardial infarction (typically from right coronary artery occlusion) causes acute RV dilatation and acute TR through both acute RV dysfunction and papillary muscle injury. This occurs in 10-15% of inferior wall MIs and may require urgent intervention.

• Atrial Fibrillation: Atrial fibrillation increases TR incidence through multiple mechanisms: loss of atrial contribution to RV filling reduces RV output efficiency, increased heart rate reduces diastolic filling time, and chronic RV volume overload from elevated ventricular filling pressures promotes RV dilatation. Approximately 30% of patients with new-onset atrial fibrillation develop or worsen TR.

• Chronic Pulmonary Disease: Chronic obstructive pulmonary disease (COPD), interstitial lung disease, and other conditions causing chronic hypoxia lead to pulmonary vasoconstriction and cor pulmonale (RV hypertrophy and dilatation), frequently accompanied by significant secondary TR.

Primary (Organic) Tricuspid Regurgitation (10-15% of significant TR cases)

• Infective Endocarditis: Particularly common in intravenous drug users (IVDU), where Staphylococcus aureus (>50% of cases) causes vegetation formation on tricuspid valve leaflets with subsequent perforation and severe acute regurgitation. The classic presentation is fever, murmur, and septic pulmonary emboli in an IVDU. Fungal endocarditis (Candida species) also occurs in immunocompromised hosts with central lines.

• Rheumatic Heart Disease: Chronic rheumatic fever causes commissural fusion and leaflet thickening of the tricuspid valve, typically in conjunction with mitral and aortic valve involvement. This is more common in developing nations and presents years to decades after the initial acute rheumatic fever episode.

• Carcinoid Syndrome: Neuroendocrine tumors secreting serotonin and tachykinins cause endocardial fibrosis and retraction of tricuspid valve leaflets, producing progressive TR (and often stenosis). Carcinoid heart disease affects ~25% of patients with carcinoid syndrome and represents one of the most common causes of primary TR in developed nations.

• Myxomatous Degeneration (Tricuspid Valve Prolapse): Less common than mitral prolapse but can cause progressive TR, especially when associated with connective tissue disorders like Marfan syndrome or Ehlers-Danlos syndrome.

• Congenital Abnormalities: Ebstein anomaly is characterized by apical displacement of the tricuspid valve leaflets, creating a large atrialized RV chamber and severe regurgitation; this diagnosis should be considered in young patients with cyanosis, tachyarrhythmias, or RV dysfunction. Tricuspid agenesis presents with severe cyanosis and requires right-to-left shunting for survival.

• Traumatic Valve Injury: Blunt chest trauma or cardiac catheterization complications can cause acute leaflet perforation or chordal rupture with acute severe regurgitation.

• Radiation Therapy: Mediastinal radiation (for lymphoma, breast cancer, or other malignancies) causes chronic pericarditis and restrictive physiology with secondary RV dilatation and TR, usually manifesting years after treatment.

• Drug-Induced TR: Anorexigenic agents (phentermine, fenfluramine), ergot alkaloids, methamphetamine, and cocaine can cause valvular fibrosis and regurgitation through catecholamine excess and serotonin signaling; fenfluramine-phentermine combination therapy caused TR in ~25% of users during its period of availability.

• Pacemaker/ICD Lead-Related: Implanted leads can mechanically interfere with normal tricuspid valve closure, traumatize valve leaflets, or cause fibrosis, resulting in lead-related TR that may or may not resolve upon lead removal.

Cardinal Symptoms

• Dyspnea: Present in 60-70% of patients with significant TR, though typically less severe than in left heart failure at equivalent degrees of ventricular dysfunction due to reduced RV output limiting pulmonary blood flow; dyspnea is often worse when supine due to increased venous return to the right heart ("orthopnea" in RV failure is less common than in LV failure but occurs in severe cases)

• Fatigue and Reduced Exercise Tolerance: Results from diminished cardiac output and inadequate increase in output with exertion; RV dysfunction impairs the normal increase in cardiac output during stress, limiting exercise capacity. Patients report inability to perform previously tolerated activities and experience exertional syncope in severe cases.

• Abdominal Discomfort and Early Satiety: Hepatomegaly and hepatic congestion cause right upper quadrant pain or aching; congestive hepatomegaly compresses the hepatic portal vein, producing splanchnic congestion and early satiety with meals. Patients may report abdominal bloating and weight gain from fluid retention.

• Lower Extremity Swelling: Dependent peripheral edema develops from systemic venous hypertension; in ambulatory patients this is ankle/pretibial, while in bedbound patients sacral edema predominates. Edema characteristically worsens as the day progresses (gravity-dependent) and improves with leg elevation.

Physical Examination Findings

• Elevated Jugular Venous Pressure (JVP): The hallmark physical sign of elevated RA pressure; normal JVP is ≤4 cm H₂O measured at the sternal angle with the patient supine or semi-upright. In significant TR, prominent systolic x descent (rapid early emptying phase) is replaced by a prominent systolic wave (s wave) or cv wave—this represents fusion of the c and v waves into a single "cv wave" and is pathognomonic for severe TR. Assessment of hepatojugular reflux (HJR)—distension of jugular veins with sustained pressure over the liver for 10 seconds—indicates hepatic congestion and RV failure; normal HJR should not exceed 4 cm additional rise in JVP.

• Hepatomegaly with Pulsatile Quality: The liver edge extends >3 cm below the costal margin and demonstrates a prominent systolic hepatic pulsation that can be palpated or visualized. This hepatic pulsation occurs because the regurgitant jet creates a systolic pressure wave that propagates back through the hepatic veins into the liver parenchyma. Hepatic pulsation is highly specific for significant TR (>90% specificity) but may be absent if severe TR coexists with atrial fibrillation (loss of atrial "kick").

• Tricuspid Regurgitation Murmur: A high-pitched, holosystolic (pansystolic) murmur audible at the left lower sternal border, increasing with inspiration (Carvallo sign). The inspiratory augmentation occurs because increased venous return with inspiration further distends the RV, worsening annular dilatation and increasing regurgitant flow. Notably, the murmur may be soft or inaudible if the regurgitant jet is low-velocity (as in severe acute TR where RA pressure remains relatively low) or if significant RV dysfunction limits flow velocity.

• Right Ventricular Heave: A sustained pulsation at the left parasternal border (left lower sternal border) indicating RV hypertrophy and enlargement; this reflects chronic RV pressure or volume overload and is present in 50-70% of moderate-to-severe TR cases.

• Peripheral Edema and Ascites: In advanced disease, patients develop pitting dependent edema, ascites (from hepatic congestion and portal hypertension), and anasarca with skin changes including livedo reticularis. Weight gain from fluid retention may be substantial (10-20 lbs over days to weeks).

• Atrial Fibrillation: Irregular pulse without respiratory variation; present in 50% of patients with significant chronic TR and represents both a consequence of RA dilatation and a contributing factor to further deterioration.

Important Clinical Variants

• Acute Severe TR (e.g., from endocarditis, trauma, papillary muscle rupture): Presents with acute cardiogenic shock with hypotension, cool extremities, altered mental status, and pulmonary edema—the acute volume load on an unprepared RV with sudden annular expansion produces acute decompensation. Physical examination may be less impressive than expected because the markedly elevated RA pressure produces sudden shock physiology rather than chronic compensatory changes.

• Isolated RV Infarction with Acute TR: Presents with acute TR in the context of inferior wall MI; these patients are particularly preload-dependent and may decompensate severely with

Initial studies

• ECG: non-diagnostic but supportive — right axis deviation, right atrial enlargement (P pulmonale), incomplete or complete RBBB, and atrial fibrillation. In Ebstein anomaly look for a pre-excitation pattern (WPW) from an accessory pathway.
• Chest radiograph: enlarged cardiac silhouette from right atrial and RV dilatation; the RV fills the retrosternal space on lateral view.
• Laboratory clues of congestion: elevated natriuretic peptides, cholestatic liver chemistries (elevated alkaline phosphatase and direct bilirubin), and a rising creatinine reflecting congestive nephropathy.

Confirmatory test — transthoracic echocardiography

• TTE with color and spectral Doppler is the diagnostic standard and, per the ACC/AHA 2020 Valvular Heart Disease Guideline, is used to assign stage A–D based on valve anatomy, regurgitant severity, hemodynamics, and symptoms.
• Features favoring severe TR (American Society of Echocardiography criteria): a wide vena contracta (roughly ≥7 mm), large effective regurgitant orifice area by PISA (approximately ≥40 mm²), a dense dagger-shaped, early-peaking triangular continuous-wave jet, systolic flow reversal in the hepatic veins, a dilated non-collapsing IVC, and tricuspid annular dilatation.
• Key pitfall: RV systolic pressure estimated from the TR jet (modified Bernoulli, 4v² + RA pressure) is underestimated in torrential TR because RV and RA pressures equalize — a low jet velocity does not exclude severe disease.
• Assess mechanism: normal leaflets with a dilated tethered annulus indicates secondary TR; thickened/retracted leaflets suggest carcinoid or rheumatic disease; vegetations suggest endocarditis; apically displaced septal leaflet with an atrialized RV defines Ebstein anomaly. A lead crossing the valve suggests device-related TR.

Adjunctive testing

• TEE when TTE windows are poor or endocarditis/lead impingement is suspected.
• Cardiac MRI is the reference standard for RV volumes, ejection fraction, and regurgitant volume when echo is discordant.
• Right heart catheterization: giant cv wave with loss of the x descent and ventricularization of the RA tracing; also quantifies pulmonary pressures before surgery.

Stabilize and treat the driver first

• Acute severe TR (endocarditis with leaflet destruction, trauma, chordal rupture) presenting with shock requires ICU care, cultures and antibiotics, and urgent surgical consultation; inotropic support with an inodilator such as milrinone or dobutamine supports the failing RV while avoiding a rise in pulmonary vascular resistance.
• RV infarction with acute TR: give volume and avoid preload-reducing agents — nitrates, high-dose diuretics, and morphine are contraindicated because these patients are preload-dependent. Reperfusion of the right coronary artery is the priority.

Medical therapy (symptom control; does not fix the valve)

• Loop diuretics (e.g., furosemide) are first-line for systemic venous congestion, hepatomegaly, ascites, and edema; the ACC/AHA 2020 valvular guideline supports diuretics for symptomatic severe TR with right heart failure.
• Aldosterone antagonists (e.g., spironolactone) counter the secondary hyperaldosteronism of hepatic congestion and add to loop diuretic efficacy.
• Treat the underlying cause, which is definitive for most secondary TR: full guideline-directed medical therapy for HFrEF per the AHA/ACC/HFSA 2022 heart failure guideline — ARNI (or ACEI/ARB), beta blocker, MRA, and SGLT2 inhibitor; pulmonary vasodilators only for appropriately classified pulmonary arterial hypertension; rate or rhythm control of atrial fibrillation; targeted antibiotics for endocarditis; somatostatin analogs for carcinoid.

Surgical and transcatheter management (ACC/AHA 2020)

• Concomitant tricuspid repair is recommended (Class 1) in patients with severe TR undergoing left-sided valve surgery, and is reasonable in lesser TR with annular dilatation or prior right heart failure.
• Isolated tricuspid valve surgery is reasonable for symptomatic severe primary TR refractory to medical therapy and for progressive RV dilatation/dysfunction before end-stage remodeling; operating late, after irreversible RV failure and cardiac cirrhosis, carries high operative mortality.
• Repair (annuloplasty ring) is preferred over replacement; when replacement is needed, a bioprosthesis is generally favored in the tricuspid position given mechanical valve thrombosis risk in a low-pressure system.
• Transcatheter tricuspid therapies (edge-to-edge repair, transcatheter valve replacement) are options for selected high-surgical-risk patients.
• Avoid isolated valve surgery in fixed severe pulmonary hypertension with end-stage RV failure — the RV cannot tolerate loss of its "pop-off."

Complications of the disease

• Progressive right heart failure: chronic volume overload dilates the RV, worsening annular dilatation — TR begets TR. Signaled by rising JVP, refractory ascites, and falling forward output with narrow pulse pressure.
• Congestive hepatopathy and cardiac cirrhosis: sustained hepatic venous pressure causes centrilobular congestion, necrosis, and fibrosis. Watch for a pulsatile then shrinking firm liver, rising bilirubin and INR, hypoalbuminemia, and eventually portal hypertension and cardiac cachexia. A markedly rising transaminase level with hypotension indicates acute ischemic "shock liver" — an emergency.
• Cardiorenal syndrome: elevated renal venous pressure, not low output alone, drives the fall in GFR; diuretic resistance with worsening creatinine is the signal.
• Atrial fibrillation and atrial flutter from right atrial stretch, with thromboembolic risk.
• Paradoxical embolism: right-to-left shunting across a patent foramen ovale when RA pressure exceeds LA pressure — presents as cryptogenic stroke or refractory hypoxemia; stroke is an emergency.
• Septic pulmonary emboli in tricuspid endocarditis: multiple peripheral nodular/cavitary lung lesions with fever and hypoxemia — an emergency requiring cultures, antibiotics, and surgical evaluation.
• Low-output cardiogenic shock in acute severe TR, when an unconditioned thin-walled RV faces sudden volume load.

Complications of treatment

• Over-diuresis: the dilated RV is preload-dependent; excessive diuresis produces hypotension, prerenal azotemia, and contraction alkalosis. Hypokalemia and hypomagnesemia predispose to ventricular arrhythmia.
• Complete heart block after tricuspid annuloplasty or replacement: the AV node lies in the triangle of Koch adjacent to the septal leaflet; new bradycardia or wide-complex escape post-op signals the need for permanent pacing — often epicardial, since a transvalvular lead would worsen TR or cross a prosthesis.
• Prosthetic valve thrombosis, more common with mechanical valves in the low-flow tricuspid position; presents as recurrent right heart failure with an increased transvalvular gradient.
• Device lead–induced TR after pacemaker/ICD implantation from leaflet impingement or adhesion.
• Perioperative RV failure and low cardiac output syndrome, the reason late isolated tricuspid surgery carries high mortality.

• The murmur that grows with inspiration: a holosystolic murmur at the left lower sternal border that intensifies with inspiration is Carvallo sign — TR. The classic distractor is mitral regurgitation, which is loudest at the apex, radiates to the axilla, and does not augment with inspiration (left-sided murmurs soften with inspiration).
• Neck and liver findings seal the diagnosis: a giant cv wave with loss of the x descent plus a pulsatile liver is the exam-favorite pairing for severe TR.
• IVDU with fever, no left-sided murmur, and multiple peripheral cavitary lung nodules = Staphylococcus aureus tricuspid endocarditis with septic pulmonary emboli. The single best next step is blood cultures before antibiotics, then echocardiography; treatment is antistaphylococcal therapy, not immediate surgery in most cases.
• Carcinoid heart disease hits the right heart because the lungs inactivate serotonin (monoamine oxidase). Look for TR plus pulmonic stenosis with flushing and diarrhea and elevated urinary 5-HIAA. Left-sided carcinoid valve disease should prompt a search for a patent foramen ovale or a primary bronchial carcinoid.
• Ebstein anomaly: apically displaced septal leaflet with an atrialized RV, associated with maternal lithium exposure and with WPW/accessory pathways — a young patient with TR and a delta wave or SVT.
• Most significant TR is secondary, so the answer to "best management" is usually treat the left-sided disease or pulmonary hypertension, not operate on the tricuspid valve. Diuretics relieve congestion but do not alter valve mechanics.
• Do not trust the TR jet velocity in torrential TR — RA and RV pressures equalize, so the estimated RV systolic pressure is falsely low; this is not evidence against severe disease.
• RV infarction with acute TR is preload-dependent: give IV fluids and reperfuse; nitrates, morphine, and aggressive diuresis can precipitate profound hypotension.
• Timing matters: per the ACC/AHA 2020 valvular guideline, severe TR should be repaired at the time of left-sided valve surgery rather than deferred — waiting until end-stage RV failure and cardiac cirrhosis makes isolated reoperation high-risk.